Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3732804015 | Idarucizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3732805019 | Product containing only idarucizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2830721000001117 | Idarucizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2830741000001110 | Idarucizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Idarucizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Idarucizumab | Has active ingredient | Idarucizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Idarucizumab | Is a | Product containing idarucizumab | true | Inferred relationship | Existential restriction modifier | ||
| Idarucizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only idarucizumab in parenteral dose form (medicinal product form) | Is a | True | Idarucizumab | Inferred relationship | Existential restriction modifier | |
| Idarucizumab 2.5g/50ml solution for infusion vials | Is a | True | Idarucizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR